MASEN MARTIN, NP
Acute Care Nurse Practitioner · SALEM, OR
Individual Active NPI 1376920439
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 204 | 73,721 | $1,967,215 | $785,353 | $620,604 |
| 2023 | 37 | 9,682 | $781,844 | $281,334 | $223,934 |
| 2022 | 156 | 37,186 | $3,692,181 | $689,470 | $550,266 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 32,960 | $1 | $1 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 7,140 | $11 | $8 |
| J1306 | Injection, inclisiran, 1 mg | 4,544 | $12 | $9 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,451 | $12 | $10 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,125 | $42 | $34 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,830 | $32 | $25 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 109 | $52 | $41 |
| 96372 | Injection of drug or substance under skin or into muscle | 109 | $12 | $9 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 88 | $106 | $85 |
| 96415 | Administration of chemotherapy into vein, each additional hour | 28 | $23 | $18 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Acute Care Nurse Practitioner | 363LA2100X | ✓ | AP138447 | TX |
| Nurse Practitioner | 363L00000X | 201502374NP | OR |
Medicare eligibility
- Part B
- No
- DME
- Yes
- Home health
- No
- Power mobility
- Yes
- Hospice
- No
Other Acute Care Nurse Practitioner providers in Oregon
- NPI 1831883347
- NPI 1801467261
- NPI 1073403069
- NPI 1457198285
- NPI 1033774955
- NPI 1316655665
- NPI 1992577118
- NPI 1033827589
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.